Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology. in Practice|January 15, 2022
Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Norma P M Rubini, Mario C Pires, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2013
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE studyLudwig Kappos, Ralf Gold, Douglas L Arnold, et al.
Pediatric Dermatology|January 27, 2022
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial dataAmy S Paller, Lisa A Beck, Andrew Blauvelt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2013
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM studyMariko Kita, Robert J Fox, J Theodore Phillips, et al.
Pediatric Dermatology|November 12, 2024
Low Infection Rates With Long-Term Dupilumab Treatment in Patients Aged 6 Months to 5 Years: An Open-Label Extension StudyAmy S Paller, Michele Ramien, Michael J Cork, et al.
Plos One|April 7, 2026
FAVABEAN and FALAPhyl: Open-source pipelines for scalable 16s rRNA microbiome data processing and visualizationAfnan Faridoun, Ramon Carvalho, Jacob Smith, et al.
African Journal of Laboratory Medicine|July 7, 2018
Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural MalawiAnnie Zhang, Enoch Jumbe, Robert Krysiak, et al.
Advances in Therapy|April 18, 2026
Long-Term Dupilumab Treatment Is Not Associated with an Increased Overall Risk of Infections in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label 5-Year Extension StudyLisa A Beck, Eric L Simpson, Diamant Thaçi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 23, 2023
Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis SkinDonald Y M Leung, Robert Bissonnette, Simion Kreimer, et al.
Allergy|July 11, 2022
Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitisEvgeny Berdyshev, Elena Goleva, Robert Bissonnette, et al.
Pageof 6